Tocilizumab and Corticosteroids Increase Risk of COVID-19-Associated Pulmonary Aspergillosis Development Among Critically Ill Patients

Am J Ther. 2023 May 1;30(3):e268-e274. doi: 10.1097/MJT.0000000000001617.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adrenal Cortex Hormones / adverse effects
  • COVID-19 Drug Treatment
  • COVID-19* / complications
  • Critical Illness / therapy
  • Humans
  • Pulmonary Aspergillosis* / drug therapy

Substances

  • tocilizumab
  • Adrenal Cortex Hormones